ArticleInternational urogynecology journal2026
Treatment of Pelvic Organ Prolapse by Robotic Sacrocolpopexy: Long-Term Outcomes.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Urinary Functional Outcomes and Prolapse Recurrence After Laparoscopic Sacrocolpopexy: A 400-Patient Single-Centre Study.International urogynecology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPelvic organ prolapse (POP) is a common condition in women, often associated with substantial morbidity. Robotic-assisted sacrocolpopexy (RASC) has been developed as a minimally invasive option for POP repair, potentially improving outcomes compared with conventional techniques. This study aimed to assess long-term anatomical and functional results of RASC in a single-institution cohort.
methodsA retrospective cohort study was conducted including women aged ≥18 years with symptomatic POP stages II-IV who underwent RASC between 2016 and 2021. Patients with a minimum follow-up of 4 years were analyzed. The primary endpoint was anatomical and subjective correction of POP. Secondary outcomes included perioperative complications, functional outcomes, and patient satisfaction. Data were obtained from clinical interviews, physical examinations, and validated questionnaires.
resultsForty-five patients were included, with a mean age of 64.7 years and a median follow-up of 55 months. Most patients had advanced prolapse, with 73.3% presenting grade III and 22.3% grade IV according to the Baden-Walker classification. Anatomical and subjective correction was achieved in 88.9% of cases, with only one patient requiring reintervention for recurrence. Early complications occurred in 6.7% of patients, all Clavien-Dindo grade I-II. Late complications included de novo constipation (15.6%) and urinary symptoms (22.2%). Overall, 95.6% of patients reported improvement and high satisfaction postoperatively.
conclusionRASC is a safe and effective option for the treatment of POP, providing durable anatomical and functional improvements with high patient satisfaction at long-term follow-up.
Indexed as
Identifiers
41273377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.